Carillon Tower Advisers’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$101M Buy
395,919
+195,791
+98% +$48.6M 0.62% 37
2020
Q3
$47.3M Sell
200,128
-376,330
-65% -$79.3M 0.63% 19
2020
Q2
$112M Buy
576,458
+48,319
+9% +$9.24M 0.86% 16
2020
Q1
$84.6M Buy
+528,139
New +$96.5M 0.83% 18
2019
Q4
Sell
-524,087
Closed -$86.4M 481
2019
Q3
$86.4M Buy
524,087
+258,424
+97% +$36.3M 0.6% 29
2019
Q2
$31.7M Hold
265,663
0.22% 163
2019
Q1
$25.3M Sell
265,663
-138,692
-34% -$11.9M 0.18% 212
2018
Q4
$32.1M Hold
404,355
0.27% 146
2018
Q3
$42.8M Hold
404,355
0.31% 128
2018
Q2
$34.7M Buy
404,355
+9,372
+2% +$841K 0.27% 135
2018
Q1
$33.6M Buy
+394,983
New +$30.7M 0.26% 132

Other funds holding PODD

Carillon Tower Advisers's PODD Position: Q4 2020 in Review

Carillon Tower Advisers increased its Insulet (PODD) stake by 98% in Q4 2020, buying an estimated $48.6M and bringing the position to 395,919 shares worth $101M. The position accounts for 0.62% of the portfolio, ranked #37.

Carillon Tower Advisers first reported a position in PODD in Q1 2018 and has held it in 11 quarters since. The position peaked at $112M in Q2 2020. 464 funds tracked by Wall St. Rank hold PODD as of Q4 2020.

  • Carillon Tower Advisers held 395,919 shares of Insulet worth $101M as of Q4 2020.
  • Carillon Tower Advisers bought 195,791 Insulet shares in Q4 2020, an estimated $48.6M.
  • Insulet made up 0.62% of Carillon Tower Advisers's portfolio in Q4 2020, its #37 holding.
  • Carillon Tower Advisers first reported a position in Insulet in Q1 2018 and has held it in 11 quarters since.
  • Carillon Tower Advisers's Insulet position peaked at $112M in Q2 2020.
  • 464 funds tracked by Wall St. Rank held Insulet as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.